Please note: Progress in Mind will close on the 31st of August. Please access or download any information you may need before then. For enquiries, contact Lundbeck at australia@lundbeck.com.
The information on this site is exclusively intended for health care professionals.
All the information in this website is intended exclusively for Australian health care professionals and contains information pertaining to locally marketed products. Content regarding medication is informative. It is the responsibility of healthcare professionals to decide, on an individual basis, the most appropriate treatment to suit the needs of the patient.
Abilify Asimtufii PBS Information: Authority required (STREAMLINED) Code: 16456 for Schizophrenia. This product is not listed on the PBS for the treatment of Bipolar I disorder
Body
Please review Approved Product Information before prescribing. Product Information is available here or by calling Lundbeck on 1300 721 277
Abilify Asimtufii® is a registered trademark of Otsuka Pharmaceutical Co., Ltd. Level 2/9 Help St, Chatswood NSW 2067, Abilify Asimtufii® is co-commercialised by Lundbeck Australia Pty Ltd and Otsuka Australia Pharmaceutical Pty Ltd.
.
Body
AU-ABAS-0033. April 2025.
Access psychiatry and neurology resources any time you need them
Progress in Mind is exclusively for Australian healthcare professionals.
Please provide details to verify you are an Australian healthcare professional.
Your privacy is important. When you register, we may collect your personal information such as your name and contact details, as outlined at 'Lundbeck and Privacy’ on our Progress in Mind website.
